Article Text

Download PDFPDF

Interferon-β-1a in relapsing-remitting multiple sclerosis: effect on hypointense lesion volume on T1 weighted images
Free
  1. Claudio Gasperinib,
  2. Carlo Pozzillia,
  3. Stefano Bastianelloa,
  4. Elisabetta Giugnia,
  5. Mark A Horsfieldc,
  6. Tatiana Koudriavtsevaa,
  7. Simona Galganib,
  8. Andrea Paolilloa,
  9. Shalom Haggiagb,
  10. Enrico Millefiorinia,
  11. Cesare Fieschia
  1. aDepartment of Neurological Sciences, University of Rome La Sapienza, Rome, Italy, bDepartment of Neurology, S Camillo Hospital, Rome, Italy, cDivision of Medical Physics, University of Leicester, UK
  1. Dr Claudio Gasperini, Department of Neurological Sciences, University LaSapienza, Viale Universita 30, Roma 00185, Italy. Telephone 0039 6 49914716; fax 0039 6 4457705. Received 26 October 1998 and in final revised form 6 July 1999

Abstract

OBJECTIVE Recently, a strong correlation between the increase in hypointense lesion load on T1 weighted spin echo images, and the increase in disability was reported. Although the effect of interferon-β has been demonstrated both in reducing exacerbation rate, frequency of enhancing lesions, and accumulation of disease burden on T2 weighted images, the impact on the accumulation of hypointense lesions has not yet been evaluated. The aims of the present study were: (a) to assess for the first time the effect of interferon-β-1a on T1 weighted MRI hypointense lesion volume; and (b) to evaluate the relation between changes on hypointense, hyperintense, and enhancing lesion volume before and during interferon-β-1a treatment in relapsing-remitting multiple sclerosis.

METHODS After a baseline scan and 6 month pretreatment period, 67 patients with relapsing-remitting multiple sclerosis were treated with interferon-β-1a by subcutaneous injection three times a week during a 12 month treatment period. All patients had MRI every month during the 6 month pretreatment period and for the first 9 months of the treatment period. A final MRI was also performed at the end of the 12 month treatment period.

RESULTS There was a significant increase in the mean hyperintense lesion volume during the pretreatment phase (6 months) and a slight decrease during the treatment period (12 months), whereas the hypointense lesion volume increased significantly before treatment and remained substantially stable during treatment. There was a significant correlation between changes in hypointense and hyperintense lesion volume during the observation period, but not during treatment. The monthly mean volume of Gadolinium-DTPA enhancing lesions was significantly higher during the pretreatment than the treatment period, and the enhancing lesion volume correlated with changes of hyperintense and hypointense lesion volumes only during the observation period.

CONCLUSION These data suggest that interferon-β-1a has a stabilising effect on T1 weighted hypointense lesion volume.

  • multiple sclerosis
  • relapsing remitting
  • magnetic resonance imaging
  • disability
  • interferon-β
  • therapy

Statistics from Altmetric.com

Footnotes

    Request Permissions

    If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.